Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction - Wikidata - awgldk - TriplyDB

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

http://www.wikidata.org/entity/Q33771334

about

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

http://www.wikidata.org/entity/Q33771334

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

@ast

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

@en

type

label

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

@ast

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

@en

prefLabel

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

@ast

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

@en

P1433

Q33771334-3A3495CB-5DE2-43B0-B83C-8391F97BFAEC

P1476

Q33771334-5CBD5320-4297-492F-BFEE-EFC2C9A72460

P2093

Q33771334-4A96E649-AC4C-486C-A170-229F3A09649D

Q33771334-56D3F130-B848-43FF-87B3-31A8B67BD70A

Q33771334-7F828753-3F4B-47E8-BD38-79E5BC68E518

Q33771334-8DDAB4C7-9C89-4C86-ACCF-08AC9821CA3C

Q33771334-AF715F55-6BC8-426D-A525-A33C9EC3C300

Q33771334-B7DD64C6-D702-49EC-B32E-18A7BB40295E

Q33771334-E26ADD54-EE41-4E1E-BFBF-C5B7A75AEEEB

P2860

Q33771334-03B80B5D-92F7-492D-AB48-AF7CEF81C681

Q33771334-044A32F2-3BDB-47B9-9961-733E83DD7E4D

Q33771334-085E677B-3CB0-4456-B149-47C96A8A2BF1

Q33771334-181C6BA7-40DC-4FB7-B80E-7FBD1FAD6941

Q33771334-19B4D33F-EE58-413D-AF10-EC1184E79AE2

Q33771334-1A7FFBCE-4258-4072-9228-22E1224BF3EF

Q33771334-313123D2-95FF-4BC9-B61B-BAC87A9995AE

Q33771334-3A9B95B6-6FD0-4173-82A6-9CF1EB0950F9

Q33771334-3EA60359-ED71-4D86-9A4B-6B6A411E06EB

Q33771334-3ED3FAB8-184C-4B6B-9730-55F020578ED9

P2888

Q33771334-29901290-B950-42FA-B017-0C69391FFC91

P304

Q33771334-3FE543FB-0D8E-4623-94C6-BDBDCC18659F

P31

Q33771334-FD70B356-0278-4CDD-A731-994D8731B8D5

P356

Q33771334-08169503-3DF2-44D2-AED6-2C0FF1896E8D

P407

Q33771334-B4111B13-DB51-4EB1-87B6-4B061B178D75

P433

Q33771334-8C437951-6461-40D4-BF57-62F42921FA2D

P478

Q33771334-04190473-1C87-463F-9DBC-3CCA30870BAE

P50

Q33771334-547EE78E-A761-4EE0-B02D-EE4262B87FC5

P577

Q33771334-C184B517-947F-481E-9AA0-209E2BF9356B

P6179

Q33771334-550BCDCD-46D8-4507-B8E4-02F02E089D37

P698

Q33771334-8428403B-235B-43BE-BF3D-A4CB3E2F6B79

P932

Q33771334-FD13C2FC-FE3B-4CCE-9841-49930BA83325

P356

S12933-017-0553-3

P1433

Cardiovascular Diabetology

P1476

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

@en

P2093

Bo Li

http://www.w3.org/2001/XMLSchema#string

Jing-Wei Li

http://www.w3.org/2001/XMLSchema#string

Qi You

http://www.w3.org/2001/XMLSchema#string

Tian-Wen Han

http://www.w3.org/2001/XMLSchema#string

Wei-Ren Chen

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Yun-Dai Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.

Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.

The glucagon-like peptides.

Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.

Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats.

Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease.

P2888

s12933-017-0553-3

P304

72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-017-0553-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085900757

http://www.w3.org/2001/XMLSchema#string

P698

28587613

http://www.w3.org/2001/XMLSchema#string

P932

5461628

http://www.w3.org/2001/XMLSchema#string